These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 11446026

  • 1. [Decreased platelet aggregation during angiotensin-converting enzyme inhibitor therapy. Results of a pilot study].
    Skowasch D, Lentini S, Andrié R, Jabs A, Bauriedel G.
    Dtsch Med Wochenschr; 2001 Jun 15; 126(24):707-11. PubMed ID: 11446026
    [Abstract] [Full Text] [Related]

  • 2. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.
    Bauriedel G, Skowasch D, Schneider M, Andrié R, Jabs A, Lüderitz B.
    Am Heart J; 2003 Feb 15; 145(2):343-8. PubMed ID: 12595854
    [Abstract] [Full Text] [Related]

  • 3. Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril.
    Skowasch D, Viktor A, Schneider-Schmitt M, Lüderitz B, Nickenig G, Bauriedel G.
    Clin Res Cardiol; 2006 Apr 15; 95(4):212-6. PubMed ID: 16598590
    [Abstract] [Full Text] [Related]

  • 4. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
    Serebruany VL, Malinin AI, Jerome SD, Lowry DR, Morgan AW, Sane DC, Tanguay JF, Steinhubl SR, O'connor CM.
    Am Heart J; 2003 Oct 15; 146(4):713-20. PubMed ID: 14564328
    [Abstract] [Full Text] [Related]

  • 5. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study.
    Velik-Salchner C, Maier S, Innerhofer P, Kolbitsch C, Streif W, Mittermayr M, Praxmarer M, Fries D.
    Anesth Analg; 2009 Jun 15; 108(6):1747-54. PubMed ID: 19448196
    [Abstract] [Full Text] [Related]

  • 6. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
    Kitai T, Nishikawa M, Tanigawa T, Okinaka T, Wada H, Shiku H, Ikeda Y, Ito M, Isaka N, Nakano T.
    Am Heart J; 2001 Aug 15; 142(2):E1. PubMed ID: 11479480
    [Abstract] [Full Text] [Related]

  • 7. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study.
    Velik-Salchner C, Maier S, Innerhofer P, Streif W, Klingler A, Kolbitsch C, Fries D.
    Anesth Analg; 2008 Dec 15; 107(6):1798-806. PubMed ID: 19020120
    [Abstract] [Full Text] [Related]

  • 8. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
    Li J, Jian Z, Huang L, Guo H, Huang J, Qian D, Fu W, Li A, Song Y.
    Biomed Pharmacother; 2009 Sep 15; 63(8):608-12. PubMed ID: 19019624
    [Abstract] [Full Text] [Related]

  • 9. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K, Inoue M, Morikawa M, Tsuboi M, Takanami Y, Iwane Y, Kudo T.
    Res Commun Chem Pathol Pharmacol; 1991 Nov 15; 74(2):153-65. PubMed ID: 1811279
    [Abstract] [Full Text] [Related]

  • 10. Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients.
    Ohmori T, Yatomi Y, Nonaka T, Kobayashi Y, Madoiwa S, Mimuro J, Ozaki Y, Sakata Y.
    J Thromb Haemost; 2006 Jun 15; 4(6):1271-8. PubMed ID: 16706971
    [Abstract] [Full Text] [Related]

  • 11. Diabetes mellitus is associated with increased ex vivo-platelet aggregation and decreased response to aspirin - antithrombotic potential of ACE-inhibitors and AT1-antagonists.
    Skowasch D, Tuleta I, Viktor A, Bauriedel G, Nickenig G.
    Platelets; 2009 Aug 15; 20(5):358-9. PubMed ID: 19579086
    [No Abstract] [Full Text] [Related]

  • 12. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
    Sbrana S, Della Pina F, Rizza A, Buffa M, De Filippis R, Gianetti J, Clerico A.
    Cytometry B Clin Cytom; 2008 Jan 15; 74(1):30-9. PubMed ID: 17630652
    [Abstract] [Full Text] [Related]

  • 13. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 15; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US.
    Circulation; 2007 Jun 26; 115(25):3156-64. PubMed ID: 17562955
    [Abstract] [Full Text] [Related]

  • 15. Use and cost of branded and generic drugs in patients with coronary heart disease--results from a prospective survey of 1008 patients in two London hospitals.
    Corp EV, Antoniou S, Wright PG, Khachi H, Vercaeren S, Wald DS.
    QJM; 2009 Dec 26; 102(12):843-9. PubMed ID: 19828644
    [Abstract] [Full Text] [Related]

  • 16. Optimal medical management of peripheral arterial disease.
    Rice TW, Lumsden AB.
    Vasc Endovascular Surg; 2006 Dec 26; 40(4):312-27. PubMed ID: 16959725
    [Abstract] [Full Text] [Related]

  • 17. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM, Reininger AJ, Toth O, Deckmyn H, Brandl R, Siess W.
    Thromb Haemost; 2007 Mar 26; 97(3):435-43. PubMed ID: 17334511
    [Abstract] [Full Text] [Related]

  • 18. Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study.
    Adamopoulos AB, Sakizlis GN, Nasothimiou EG, Anastasopoulou I, Anastasakou E, Kotsi P, Karafoulidou A, Stergiou GS.
    J Cardiovasc Pharmacol; 2009 Aug 26; 54(2):163-8. PubMed ID: 19568178
    [Abstract] [Full Text] [Related]

  • 19. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Lawrie AS, Purdy G, Machin SJ, Brown MM.
    Platelets; 2005 Aug 26; 16(5):269-80. PubMed ID: 16011977
    [Abstract] [Full Text] [Related]

  • 20. Normalization of platelet reactivity in clopidogrel-treated subjects.
    Vilahur G, Choi BG, Zafar MU, Viles-Gonzalez JF, Vorchheimer DA, Fuster V, Badimon JJ.
    J Thromb Haemost; 2007 Jan 26; 5(1):82-90. PubMed ID: 17239165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.